Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xenon Pharmaceuticals Inc.(XENE) | 837,387 | 994,227 | +156,840 | $36.05M | $38.76M | 6.11% | +$2.72M |
| Apogee Therapeutics Inc | 592,093 | 836,283 | +244,190 | $39.34M | $32.91M | 5.18% | -$6.44M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 115,000 | 110,000 | -5,000 | $30.71M | $30.82M | 4.85% | +$108.0K |
| Arcellx Inc COMMON STOCK | 300,000 | 460,000 | +160,000 | $20.86M | $25.39M | 4.00% | +$4.52M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,400,000 | 1,450,000 | +50,000 | $19.75M | $23.56M | 3.71% | +$3.81M |
| Crinetics Pharmaceuticals In | 470,000 | 515,000 | +45,000 | $22.00M | $23.07M | 3.63% | +$1.07M |
| Cerevel Therapeutics Hldng I | 300,000 | 500,000 | +200,000 | $12.68M | $20.45M | 3.22% | +$7.76M |
| Nurix Therapeutics, Inc.(NRIX) | 810,253 | 912,000 | +101,747 | $11.91M | $19.03M | 3.00% | +$7.12M |
| Celldex Therapeutics, Inc.(CLDX) | 510,000 | 475,400 | -34,600 | $21.40M | $17.59M | 2.77% | -$3.81M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $18.30M | $17.26M | 2.72% | -$1.04M |
| Alnylam Pharmaceuticals, Inc.NOTE 1 000 9 1(ALNY) | 0 | 0 | 0 | $9.45M | $16.20M | 2.55% | +$6.75M |
| BeOne Medicines AGADR(ONC) | 82,143 | 110,000 | +27,857 | $12.85M | $15.69M | 2.47% | +$2.85M |
| Alkermes plcSHS(ALKS) | 75,000 | 650,000 | +575,000 | $2.03M | $15.66M | 2.47% | +$13.63M |
| Nuvalent Inc | 150,000 | 200,000 | +50,000 | $11.26M | $15.17M | 2.39% | +$3.91M |
| Autolus Therapeutics plcADS(AUTL) | 3,375,000 | 4,300,000 | +925,000 | $21.53M | $14.96M | 2.36% | -$6.57M |
| Vera Therapeutics, Inc.CL A(VERA) | 470,000 | 375,000 | -95,000 | $20.27M | $13.57M | 2.14% | -$6.70M |
| Kura Oncology, Inc.(KURA) | 730,492 | 650,000 | -80,492 | $15.58M | $13.38M | 2.11% | -$2.20M |
| Inozyme Pharma Inc | 2,642,519 | 2,856,252 | +213,733 | $20.24M | $12.74M | 2.01% | -$7.50M |
| Spyre Therapeutics, Inc.(SYRE) | 410,000 | 513,420 | +103,420 | $15.55M | $12.07M | 1.90% | -$3.48M |
| Climb Bio, Inc.(CLYM) | 0 | 1,670,661 | +1,670,661 | $0 | $11.88M | 1.87% | +$11.88M |
| Centessa Pharmaceuticals PlcADS | 830,546 | 1,135,702 | +305,156 | $9.39M | $10.26M | 1.62% | +$870.2K |
| Establishment Labs Holdings Inc.(ESTA) | 164,589 | 223,407 | +58,818 | $8.38M | $10.15M | 1.60% | +$1.77M |
| Verona Pharma PlcADS | 817,833 | 700,000 | -117,833 | $13.16M | $10.12M | 1.59% | -$3.04M |
| Inari Med Inc | 175,000 | 200,000 | +25,000 | $8.40M | $9.63M | 1.52% | +$1.23M |
| Immunovant, Inc.(IMVT) | 285,000 | 346,088 | +61,088 | $9.21M | $9.14M | 1.44% | -$71.6K |
| Astria Therapeutics Inc | 845,606 | 975,606 | +130,000 | $11.90M | $8.88M | 1.40% | -$3.02M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $5.78M | $8.64M | 1.36% | +$2.85M |
| Morphic Hldg Inc | 225,000 | 250,573 | +25,573 | $7.92M | $8.54M | 1.34% | +$617.0K |
| Insmed Incorporated(INSM) | 0 | 125,000 | +125,000 | $0 | $8.38M | 1.32% | +$8.38M |
| Newamsterdam Pharma Company ORDINARY SHARES | 286,200 | 423,155 | +136,955 | $6.77M | $8.13M | 1.28% | +$1.36M |
| Omeros CorpNOTE 5 250 2 1 | 0 | 0 | 0 | $7.63M | $8.08M | 1.27% | +$450.6K |
| Rezolute, Inc.(RZLT) | 1,600,000 | 1,850,000 | +250,000 | $4.08M | $7.96M | 1.25% | +$3.88M |
| Merus N V | 0 | 125,000 | +125,000 | $0 | $7.40M | 1.16% | +$7.40M |
| Axsome Therapeutics, Inc.(AXSM) | 139,758 | 80,000 | -59,758 | $11.15M | $6.44M | 1.01% | -$4.71M |
| Geron Corporation(GERN) | 2,500,000 | 1,500,000 | -1,000,000 | $8.25M | $6.36M | 1.00% | -$1.89M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $0 | $6.30M | 0.99% | +$6.30M |
| Savara Inc.(SVRA) | 1,150,000 | 1,546,850 | +396,850 | $5.73M | $6.23M | 0.98% | +$506.8K |
| Erasca, Inc.(ERAS) | 0 | 2,499,431 | +2,499,431 | $0 | $5.90M | 0.93% | +$5.90M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 550,000 | +550,000 | $0 | $5.48M | 0.86% | +$5.48M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 160,000 | 155,000 | -5,000 | $4.02M | $5.30M | 0.83% | +$1.28M |
| Cullinan Therapeutics, Inc.(CGEM) | 258,588 | 263,817 | +5,229 | $4.41M | $4.60M | 0.72% | +$194.6K |
| Vaxcyte, Inc.(PCVX) | 80,000 | 60,000 | -20,000 | $5.46M | $4.53M | 0.71% | -$934.2K |
| Elevation Oncology Inc | 1,268,825 | 1,468,825 | +200,000 | $6.51M | $3.97M | 0.62% | -$2.54M |
| Hillevax Inc | 0 | 265,859 | +265,859 | $0 | $3.84M | 0.61% | +$3.84M |
| Mineralys Therapeutics, Inc.(MLYS) | 327,959 | 327,959 | 0 | $4.23M | $3.84M | 0.60% | -$396.8K |
| Roivant Sciences Ltd.SHS(ROIV) | 500,000 | 351,587 | -148,413 | $5.27M | $3.72M | 0.59% | -$1.55M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 100,000 | +100,000 | $0 | $3.53M | 0.56% | +$3.53M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 0 | 350,000 | +350,000 | $0 | $3.52M | 0.55% | +$3.52M |
| Immatics N.V.SHS(IMTX) | 350,000 | 300,000 | -50,000 | $3.68M | $3.49M | 0.55% | -$192.5K |
| Spdr Ser TrS P BIOTECH ST STR SP BIOT | 0 | 37,550 | +37,550 | $0 | $3.48M | 0.55% | +$3.48M |
| Context Therapeutics Inc.(CNTX) | 328,817 | 1,619,140 | +1,290,323 | $453.8K | $3.25M | 0.51% | +$2.79M |
| Black Diamond Therapeutics I | 0 | 650,000 | +650,000 | $0 | $3.03M | 0.48% | +$3.03M |
| COMPASS Pathways plcADS(CMPS) | 1,027,868 | 500,512 | -527,356 | $8.55M | $3.02M | 0.48% | -$5.53M |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 275,000 | +275,000 | $0 | $2.98M | 0.47% | +$2.98M |
| Nextcure Inc | 1,359,037 | 1,687,955 | +328,918 | $3.03M | $2.68M | 0.42% | -$346.8K |
| Springworks Therapeutics Inc | 100,000 | 69,999 | -30,001 | $4.92M | $2.64M | 0.42% | -$2.29M |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.59M | $2.56M | 0.40% | -$32.5K |
| BridgeBio Pharma, Inc.(BBIO) | 50,000 | 100,000 | +50,000 | $1.55M | $2.53M | 0.40% | +$987.0K |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 150,000 | +150,000 | $0 | $1.95M | 0.31% | +$1.95M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 202,599 | 202,599 | 0 | $2.24M | $1.92M | 0.30% | -$320.1K |
| Wave Life Sciences, Inc.SHS(WVE) | 286,585 | 375,000 | +88,415 | $1.77M | $1.87M | 0.29% | +$103.0K |
| Vir Biotechnology, Inc.(VIR) | 0 | 200,000 | +200,000 | $0 | $1.78M | 0.28% | +$1.78M |
| Zymeworks Inc.(ZYME) | 0 | 191,127 | +191,127 | $0 | $1.63M | 0.26% | +$1.63M |
| Mersana Therapeutics Inc | 1,000,000 | 767,000 | -233,000 | $4.48M | $1.54M | 0.24% | -$2.94M |
| Arya Sciences Acqu Corp IvCL A | 133,500 | 133,500 | 0 | $1.50M | $1.53M | 0.24% | +$25.4K |
| ADC Therapeutics SASHS(ADCT) | 0 | 474,744 | +474,744 | $0 | $1.50M | 0.24% | +$1.50M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 200,000 | +200,000 | $0 | $1.50M | 0.24% | +$1.50M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 120,000 | 50,000 | -70,000 | $3.43M | $1.30M | 0.20% | -$2.13M |
| Tango Therapeutics, Inc.(TNGX) | 150,274 | 150,274 | 0 | $1.19M | $1.29M | 0.20% | +$96.2K |
| Nkarta, Inc.(NKTX) | 0 | 200,000 | +200,000 | $0 | $1.18M | 0.19% | +$1.18M |
| Kezar Life Sciences Inc | 1,761,778 | 1,761,778 | 0 | $1.59M | $1.06M | 0.17% | -$531.4K |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 58,331 | +58,331 | $0 | $960.7K | 0.15% | +$960.7K |
| Puma Biotechnology, Inc.(PBYI) | 0 | 250,000 | +250,000 | $0 | $815.0K | 0.13% | +$815.0K |
| Zura Bio LimitedCL A(ZURA) | 450,009 | 223,335 | -226,674 | $1.16M | $781.7K | 0.12% | -$374.9K |
| Avalo Therapeutics, Inc.(AVTX) | 10,000 | 45,000 | +35,000 | $217.5K | $561.1K | 0.09% | +$343.6K |
| Q32 Bio Inc.(QTTB) | 27,777 | 27,777 | 0 | $473.3K | $498.6K | 0.08% | +$25.3K |
| Immatics N.VW EXP 07 01 202 | 187,204 | 187,204 | 0 | $486.7K | $484.9K | 0.08% | -$1.9K |
| Neurobo Pharmaceuticals In | 0 | 89,222 | +89,222 | $0 | $431.8K | 0.07% | +$431.8K |
| Promis Neurosciences Inc | 265,958 | 265,958 | 0 | $508.0K | $398.9K | 0.06% | -$109.0K |
| Aerovate Therapeutics Inc | 0 | 200,000 | +200,000 | $0 | $332.0K | 0.05% | +$332.0K |
| Arca Biopharma Inc | 0 | 72,484 | +72,484 | $0 | $277.6K | 0.04% | +$277.6K |
| Rapt Therapeutics Inc | 0 | 75,000 | +75,000 | $0 | $228.8K | 0.04% | +$228.8K |
| Passage Bio, Inc.(PASG) | 264,266 | 264,266 | 0 | $356.8K | $209.9K | 0.03% | -$146.9K |
| Genelux Corporation(GNLX) | 0 | 100,000 | +100,000 | $0 | $195.0K | 0.03% | +$195.0K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 75,000 | 75,000 | 0 | $22.4K | $4.5K | 0.00% | -$17.9K |
| Iovance Biotherapeutics, Inc.(IOVA) | 0 | 100 | +100 | $0 | $802 | 0.00% | +$802 |
| Absci Corporation | 1,025,000 | 0 | -1,025,000 | $5.82M | $0 | — | -$5.82M |
| Apellis Pharmaceuticals Inc COM | 165,000 | 0 | -165,000 | $9.70M | $0 | — | -$9.70M |
| Avrobio Inc | 700,000 | 0 | -700,000 | $896.0K | $0 | — | -$896.0K |
| Boston Scientific Corporation(BSX) | 25,000 | 0 | -25,000 | $1.71M | $0 | — | -$1.71M |
| Cassava Sciences IncW EXP 11 15 202 | 24,200 | 0 | -24,200 | $97.5K | $0 | — | -$97.5K |
| Cytokinetics, Incorporated(CYTK) | 80,000 | 0 | -80,000 | $5.61M | $0 | — | -$5.61M |
| Fulcrum Therapeutics, Inc.(FULC) | 550,339 | 0 | -550,339 | $5.20M | $0 | — | -$5.20M |
| Intra-Cellular Therapies Inc | 50,000 | 0 | -50,000 | $3.46M | $0 | — | -$3.46M |
| Krystal Biotech, Inc.(KRYS) | 26,746 | 0 | -26,746 | $4.76M | $0 | — | -$4.76M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 75,000 | 0 | -75,000 | $3.77M | $0 | — | -$3.77M |
| Perspective Therapeutics, Inc.(CATX) | 5,100,000 | 0 | -5,100,000 | $6.07M | $0 | — | -$6.07M |
| Protagonist Therapeutics Inc | 100,000 | 0 | -100,000 | $2.89M | $0 | — | -$2.89M |
| REGENXBIO Inc.(RGNX) | 110,000 | 0 | -110,000 | $2.32M | $0 | — | -$2.32M |
| Terns Pharmaceuticals Inc | 450,000 | 0 | -450,000 | $2.95M | $0 | — | -$2.95M |